BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15656906)

  • 1. MDM2 negatively regulates the human telomerase RNA gene promoter.
    Zhao J; Bilsland A; Jackson K; Keith WN
    BMC Cancer; 2005 Jan; 5():6. PubMed ID: 15656906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pRB induces Sp1 activity by relieving inhibition mediated by MDM2.
    Johnson-Pais T; Degnin C; Thayer MJ
    Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2211-6. PubMed ID: 11226218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.
    Zhao J; Bilsland A; Hoare SF; Keith WN
    FEBS Lett; 2003 Feb; 536(1-3):111-9. PubMed ID: 12586348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3.
    Zhao JQ; Glasspool RM; Hoare SF; Bilsland A; Szatmari I; Keith WN
    Neoplasia; 2000; 2(6):531-9. PubMed ID: 11228546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.
    Bilsland AE; Stevenson K; Atkinson S; Kolch W; Keith WN
    Cancer Res; 2006 Feb; 66(3):1363-70. PubMed ID: 16452190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
    Clem AL; Hamid T; Kakar SS
    Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB, Sp1 and NF-Y as transcriptional regulators of human SND1 gene.
    Armengol S; Arretxe E; Rodríguez L; Ochoa B; Chico Y; Martínez MJ
    Biochimie; 2013 Apr; 95(4):735-42. PubMed ID: 23160072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
    Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
    J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes.
    Glasspool RM; Burns S; Hoare SF; Svensson C; Keith WN
    Neoplasia; 2005 Jun; 7(6):614-22. PubMed ID: 16036112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus up-regulates transcription of human telomerase reverse transcriptase promoter through interaction with transcription factor Sp1.
    Verma SC; Borah S; Robertson ES
    J Virol; 2004 Oct; 78(19):10348-59. PubMed ID: 15367601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional regulation of the human Sp1 gene promoter by the specificity protein (Sp) family members nuclear factor Y (NF-Y) and E2F.
    Nicolás M; Noé V; Ciudad CJ
    Biochem J; 2003 Apr; 371(Pt 2):265-75. PubMed ID: 12513689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-dependent down-regulation of telomerase is mediated by p21waf1.
    Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
    J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive regulation of promoter activity of human 3-phosphoglycerate dehydrogenase (PHGDH) gene is mediated by transcription factors Sp1 and NF-Y.
    Jun DY; Park HS; Lee JY; Baek JY; Park HK; Fukui K; Kim YH
    Gene; 2008 May; 414(1-2):106-14. PubMed ID: 18378410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1.
    Guo CS; Degnin C; Fiddler TA; Stauffer D; Thayer MJ
    J Biol Chem; 2003 Jun; 278(25):22615-22. PubMed ID: 12702724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
    Gu L; Findley HW; Zhou M
    Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Sp1-NF-Y/progesterone receptor DNA binding-dependent mechanism regulates progesterone-induced transcriptional activation of the rabbit RUSH/SMARCA3 gene.
    Hewetson A; Chilton BS
    J Biol Chem; 2003 Oct; 278(41):40177-85. PubMed ID: 12890680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression.
    Minsky N; Oren M
    Mol Cell; 2004 Nov; 16(4):631-9. PubMed ID: 15546622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-Y and Sp1 are involved in transcriptional regulation of rat SND p102 gene.
    Rodríguez L; Ochoa B; Martínez MJ
    Biochem Biophys Res Commun; 2007 Apr; 356(1):226-32. PubMed ID: 17350600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.